ZNF655 was enriched in KEGG pathways including basal cell carcinoma, calcium signaling pathway, cardiac muscle contraction, juvenile diabetes mellitus, and neuroactive ligand receptor interaction (Fig 6H). This evidence concerns the gene ZNF655 and basal cell carcinoma.